Author:
Ando Kentaro,Hombo Toshiyasu,Kanno Akihiro,Ikeda Hironobu,Imaizumi Masakazu,Shimizu Noritsugu,Sakamoto Kengo,Kitani Shin-ichi,Yamamoto Yoshinori,Hizume Shingo,Nakai Keiko,Kitayama Tetsuya,Yamamoto Keiji
Publisher
Japanese Pharmacological Society
Subject
Pharmacology,Molecular Medicine
Reference51 articles.
1. 1 ICH Harmonised Tripartite Guideline, Safety Pharmacology Studies for Human Pharmaceuticals S7A. Recommended for adoption at step 4 of the ICH process on 8 November 2000 by the ICH Steering Committee. ICH; http://www.ich.org/.
2. 2 ICH Harmonised Tripartite Guideline, The Non-clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals S7B. Recommended for adoption at step 4 of the ICH process on 12 May 2005 by the ICH Steering Committee. ICH; http://www.ich.org/.
3. HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF CISAPRIDE IN HUMAN PLASMA
4. Determination of cisapride in human plasma by high-performance liquid chromatography
5. Analysis of cisapride in neonatal plasma using high-performance liquid chromatography with a base-stable column and fluorescence detection
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献